Emerging treatments
Verapamil
May inhibit insulin secretion at high doses, but evidence to support use in hypoglycaemia is limited.
Phenytoin
May inhibit insulin secretion at high doses, but evidence to support use in hypoglycaemia is limited.
Corticosteroids
In non-operable insulin-like growth factor-II-secreting tumours, there are case reports of successful control of hypoglycaemic symptoms by using an oral glucocorticoid.[55]
Use of this content is subject to our disclaimer